1Yamamoto H, Ochiya T, Takeshita F, et al. Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation.Cancer Res,2002,62(6): 1641-1647
2Masciullo V, Scambia G, Marone M, et al. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Int J Cancer, 1997,74(4) :390-395
3Ichikawa Y,Yoshida S, Koyama Y, et al. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stage of primary ovarian tumors. Int J Cancer, 1996, 69(6):466-470
4Kudoh K, Ichikawa Y, Yoshida S, et al. Inactivation of p16/CDKN2and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer. Int J Cancer,2002,99(4) :579-582
